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ABSTRACT: The lack of data on lung function decline in the aging process as well as the lack of gold standards to 
define obstructive and restrictive respiratory disease in older people point out the need for a multidimensional 
assessment and interpretation of the aging airways. By integrating clinical data together with morphologic and 
morphometric findings clinicians can assess the airways with a more comprehensive perspective, helpful in the 
interpretation of the “grey zone” between normal aging and disease. This review focuses on the value of a 
multidimensional approach in the study of the aging airways, including clinical findings, respiratory function 
tests, and imaging as parts of a whole. Nowadays this multidimensional diagnostic approach can be used in daily 
clinical practice. In next future, it can be implemented by the analysis of exhaled gases, post-processing imaging 
techniques, and genetic analysis, that will hopefully reduce the gaps in knowledge of normal aging and airway 
disease in older people.  
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The aging process affects both structure and function of 
airways, lung parenchyma, and respiratory muscles. This 
process results in changes of the respiratory flows, with 
dynamic lung volumes decreasing and residual volume 
increasing progressively with age. Normal standards must 
be tailored to age accordingly. Indeed, the recent 
European Respiratory Society/American Thoracic 
Society Task Force for COPD Research Statement 
highlighted the importance of “aging” in defining airway 
disease by requesting new studies that “evaluate the 
impact of age on the importance of identifying an airflow 
limitation” [1]. Clinical evaluation together with 
pulmonary function tests (PFTs) is necessary to 
characterize the pattern of airway disease as well as its 
severity. However, spirometry is underused and difficult 
to perform in older people and there is no spirometric gold 
standard specific in this population for the diagnosis of 
obstructive disease. Imaging can to some extent integrate 
or also substitute for respiratory function data in highly 
problematic cases, providing important clinical 
information.  
The limitations of PFTs and imaging should promote 
efforts to combine both into a multidimensional 
assessment of the older respiratory patient, by integrating 
clinical data together with morphologic and 
morphometric findings. Nowadays such a 
multidimensional approach can be used in our daily 
clinical practice and in next future it can be implemented 
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by new diagnostic non-invasive methods, such as analysis 
of exhaled gases, post-processing imaging techniques, 
and genetic analysis.  
 
The aging airways 
 
The aging process of the airways manifests with many 
features, ranging from a decrease in dynamic lung 
volumes and mucociliary clearance to an increase in 
bronchial responsiveness. 
- Volumes. Aging is characterized by a gradual 
decrease in the surface area of airspace wall per unit of 
lung volume and enlargement of airspaces [2]. This 
finding was originally defined as “senile emphysema”, 
but it actually differs from the pathological condition of 
emphysema. Indeed, in the normal aging lung alveolar 
septa are intact and the elastic network supporting the 
small airways is only partially damaged, with alveolar 
sacs modestly enlarged [3, 4]. Accordingly, the age-
related increase in the residual volume to total lung 
capacity ratio does not reflect a true emphysematous 
change of the aging lung. Indeed, the fact that arterial 
oxygen tension and alveolar-arterial oxygen tension 
difference are stable in the healthy older people testifies 
that gas exchanges are well preserved even in the very old 
[5, 6]. Thus, the age-related decline in lung volumes does 
not affect the ventilation-to-perfusion ratio [7]. 
Individual genetic factors as well as modifiable 
factors, including smoking and environmental pollution, 
variably affect the decline of lung volume with age and 
the related shortening of telomeres in bronchial, alveolar 
and endothelial pulmonary cells [8]. The features of an 
aging lung may indeed be present even in adult or young-
adult people with an unfavorable risk profile. Among 
modifiable factors, smoking plays an important role, with 
the yearly loss of dynamic lung volumes increased up to 
100% in heavy smokers, from the usual 20-30 ml up to 60 
ml [3].  
At any age, the measured lung volume may be 
considered to depend upon the achieved volumes at the 
time of lung maturity, i.e. at age 20-25 years, and the rate 
of decline. Thus, growing optimally and adhering to a 
healthy life style in the adulthood are expected to 
guarantee for the best respiratory function even in the very 
old. 
The heterogeneity in lung function decline increases 
in the diseased lungs. In the “Eclipse” study a dramatic 
inter-individual variability in the yearly decline of forced 
expiratory volume in 1 second (FEV1) has been observed 
in patients with chronic obstructive pulmonary disease 
(COPD) (mean age 63±7, range 40-75 years) [9]. The 
median yearly loss of FEV1 was 32 ml, with 20% of 
patients loosing over 60 ml per year and 18% of patients 
with no change or only a small positive change in FEV1 
over a 3-years period [9]. 
- Mucociliary clearance. Aging is characterized by 
weakened pulmonary immune defenses and dramatically 
decreased mucociliary clearance [3]. These changes result 
in an increased susceptibility to lung infections as well as 
in an increase in incidentally found imaging findings, such 
as bronchiectases, cysts, scars, and bronchial dilation. 
These findings are variably present in older patients 
without a clear history of respiratory disease.  
- Bronchial responsiveness. Aging is associated with 
increased bronchial responsiveness to cholinergic drugs 
or non-pharmacologic stimuli. However, this does not 
translate into an age-related increase in the prevalence of 
asthma. Asthma is more common in young adults, and 
after the age of 60 years it is phenotypically different: 
uncommon history of allergic disease, nocturnal and early 
morning symptoms, poor immediate response to the 
bronchodilator. Thus, asthma is frequently unrecognized 
in this population or misclassified as COPD [10, 11]. 
Bronchial responsiveness is also associated with 
accelerated lung volume decline and correlates inversely 
with airway caliber [12].  
- Other changes. Although not directly related to the 
airways, the age-related decline in respiratory muscle 
strength (about 1% each year after age 30 [13]) accounts 
for decreased ventilatory reserve, limiting the response to 
the exercise and to stressing conditions, such as 
pneumonia or ARDS. Furthermore, pulmonary vascular 
reserve declines with age [14] and even subjects with 
well-preserved respiratory function are at risk of 
respiratory muscle exhaustion at rest and of acute 
respiratory failure in stressing conditions. 
 
Spirometry: to the limits and beyond 
 
Clinical evaluation together with PFTs are necessary to 
characterize the pattern of airway disease as well as its 
severity. Age-related decrease in dynamic lung volumes 
can be assessed through the predicted values of FEV1 and 
forced vital capacity (FVC), that present less inter-
individual variability than mid-expiratory and end-
expiratory flows [15]. The classic fixed FEV1/FVC ratio 
is a very simple definition of bronchial obstruction, but it 
physiologically declines with age [2] and can lead to an 
over-diagnosis of bronchial obstruction in older people 
[16]. Indeed, in the Sa.R.A. (Salute Respiratoria 
nell’Anziano - Respiratory health in older people) study, 
involving people aged 65 years and over, the fifth 
percentile of the FEV1/FVC distribution was 0.65 for men 
and 0.67 for women. Taking into account the classic fixed 
FEV1/FVC ratio of 0.70 as limit for obstruction, the 15% 
of the population over 65 would have been 
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inappropriately classified as obstructed [17]. Thus, the 
Lower Limit of Normal (LLN) has been proposed as an 
alternative to the fixed FEV1/FVC ratio, independent from 
clinical factors. However, there are still controversies, as 
demonstrated by two different studies in populations older 
than 65 years of age. Mannino et al. [18] found that the 
fixed FEV1/FVC ratio has greater prognostic implications 
than the LLN, whereas Luoto et al. [19] achieved opposite 
results. Although the analysis of reasons accounting for 
this discrepancy is beyond the scope of this review, 
differences in smoking habits, ethnicity, and years of 
follow-up between the populations studied should be 
taken into account.  
Another score that could be used in older people is the 
Z score, a standardized score of FEV1 independent from 
age, gender, and height. Applied to spirometric indexes, Z 
score looks like a promising diagnostic and classificatory 
tool in geriatric population [18]. Indeed, the Z score 
correlates with important clinical outcomes, such as 
respiratory symptoms in general, dyspnea-on-exertion, 
and mortality [20]. However, the available data on 
literature do not allow drawing definitive conclusions 
about the spirometric gold standard for the diagnosis of 
COPD in older people. Moreover, spirometry is 
underused in older people, as it could be difficult to 
perform especially by disabled people. In the Sa.R.A. 
study one out of five people over the age of 64 years could 
not meet American Thoracic Society/European 
Respiratory Society acceptability and/or reproducibility 
criteria for spirometry [21]. Lower education, cognitive 
impairment, and polypharmacy were independent 
predictors among the not achievers. Measuring forced 
expiratory volume in 6 seconds (FEV6) could expand the 
population with a diagnostic spirometry, but still 18% of 
probands have a bad quality test [22]. These issues about 
spirometry affect the data on longitudinal changes in 
FEV1 in COPD populations: all the available information 
stems from pharmacological trials on highly selected 
individuals. Thus, there is a lack of reliable information 
on lung function decline in frail and dependent people. 
This points out the need for a multidimensional 
assessment and interpretation of the aging airways by 
integrating spirometric data together with morphologic 
and morphometric findings and, in next future, with data 
provided by innovative diagnostic methods (see section 
“New horizons”). The general systems theory of von 
Bertalanffy [23] inspires for a multidimensional 
assessment based on a comparative analysis of PFTs, 
imaging, and physiological parameters as a function of 
age (Fig. 1). 
 
 
Figure 1. Multidimensional approach. Likewise, the match of 
primary colours generates the entire colour wheel, the match of 
physiological parameters, imaging, and pulmonary function tests 
(PFTs) allows studying the multiple facets of the airways in older 
people. They could be studied even deeply in next future by 
adding to this multidimensional approach the data provided by 
analysis of exhaled gases, post-processing imaging techniques, 
and genetic analysis. 
 
Imaging can integrate the functional assessment in 
selected conditions and can partly compensate for the vast 
proportion of older people unable to perform high quality 
PFTs, being less dependent from patient’s cooperation 
than PFTs and suitable to many probands. Although chest 
X-ray (CXR) is the first step in the evaluation of airway 
disease, findings are often subtle and can be missed. 
Therefore, computed tomography (CT) is the main 
imaging technique to assess the airways. Morphometric 
analysis of the small airways lacks a well-defined 
functional equivalent and this is especially true in older 
people. Nevertheless, imaging provides a structured 
morphometric analysis of the aged lung and useful 
information on large airways, which lack a respiratory 
function equivalent.  
Although imaging cannot directly inform about the 
respiratory function, indirect insight is valuable. For 
instance, imaging findings of air-trapping at expiratory 
scans are clearly consistent with small airway disease, that 
can be completely silent at PFTs. Furthermore, a negative 
CT scan can be very helpful in excluding a pulmonary 
origin of respiratory symptoms, suggesting alternative 
diagnoses. Finally, imaging can provide additional 
information about diaphragm mass and mobility, 
pericardial effusion, rib and vertebral fractures, ascites, 
and nervous compression, that all influence respiratory 
function. 
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Figure 2. Aging airways. Comparison between “normal” CXR in an elderly subject (A) and in a young adult (B). Postero-
anterior CXR in an 87 years-old woman (A) shows displacement of the trachea (arrow) to the right side, calcifications of 
the tracheobronchial cartilage, symmetrical bilateral reduction in lung vascularity (more prominent in middle-upper 
regions), linear and reticular opacities in lung bases (asterisks), and bronchial wall thickening. All these findings cannot 
be seen in the younger adult (B, 45 years-old woman). 
 
Imaging findings between normal aging and clinically 
relevant airway disease 
 
In older people, a grey zone exists between normal aging 
and disease, generating diagnostic issues to both 
clinicians and radiologists. The definition of normal 
radiological appearance of the airways in older people 
would be helpful in daily practice as well as in research. 
However, literature data on radiological appearance of 
aging airways in asymptomatic older individuals is scarce 
and dispersed [24, 25]. Specifics for accurate imaging 
evaluation in older people are summarized in Table 1. 
Common findings in imaging examinations of aging 
airways without a clinical relevance include the 
followings (Fig. 2): 
- Calcifications of tracheobronchial cartilage, 
evident at CXR and MDCT scans. They occur in up to 
65% of men and 41% of women in the age range of 60–
79 years [26].  
- Displacement of the trachea to the right-side usual 
in more than 30% of cases, due to the enlargement of the 
atherosclerotic aortic arch [27]. 
- Tracheal dilation and higher collapsibility. In a 
recent study O’Donnell, et al. [28] analyzed tracheal 
dimensions of 81 subjects from 25 to 75 years at both end-
inspiration and during forced expiration on CT scan. 
Relative to younger ones, older men had an average 11% 
greater cross-sectional area at end-inspiration and 40% 
smaller cross-sectional area during forced expiration. 
Conversely, older women had 14% greater mean tracheal 
area at end-inspiration, but no difference in area at 
expiration. Data at end-inspiration confirm the results of 
previously published studies on tracheal dimensions in 
CXR [29-31]. In particular, Breatnacht et al. [29] studying 
a group of patients from 10 to 79 years of age revealed 
changes in tracheal diameters till the forth decade of life 
and in the cross-sectional tracheal shape from round to 
ovoid. From the third and through the eighth decade, the 
coronal and sagittal diameters were statistically greater in 
men than in women: in the seventh decade of life the mean 
sagittal and coronal diameters were 20.7 and 19.5mm in 
men and 17.2 and 16.8mm in women respectively, and in 
the eight decades of life the mean sagittal and coronal 
diameters were 20.8 and 19.7mm in men and 16.5 and 
16.4mm in women, respectively.  
- Bronchial dilation. In 1976 a physiological study 
by Gibson et al. reported an age-related increase in 
unstressed airway dimensions and a loss of elastic recoil 
of both airways and lung parenchyma, qualitatively 
similar to that found in other tissues [32]. More recently, 
a radiological study by Matsuoka et al. [33] observed a 
mean value of bronchoarterial ratio in subjects older than 
65 years significantly higher than the one obtained in 
younger subjects (0.78 versus 0.61-0.70). Moreover, in 
41% of cases a normal bronchoarterial ratio overlaps with 
the ratio considered to be the threshold for bronchiectases 
[33]. The authors postulated the role of hypoxic 
bronchodilatation and vasoconstriction as the reason for 
the increase in the bronchoarterial ratio with aging. 
However, hypoxia is not a physiologically age-related 
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event and other age-dependent alterations in bronchial 
structure with weakening in elastic recoil would account 
for bronchial shrinkage rather than dilation. Therefore, the 
interpretation of this finding remains unclear.  
- Bronchial wall thickening. Vikgren et al. [34] 
studied 92 healthy subjects 61-62 years old and followed 
them up to 6 years later. They found bronchial wall 
thickening in 35% of never-smoker subjects at baseline 
with a substantial increase to 69% after 6 years’ follow-
up, due to the aging process. 
- Air-trapping. The frequency of air trapping 
significantly increases with age, being present in 76% of 
subjects at the age of 61 or older [35]. Moreover, the 
extent of air-trapping has a significant correlation with 
age as well as with a smoking history of more than 10 
pack-years [35]. By using a new technique of co-
registration analysis of paired inspiratory and expiratory 
CT scans (see section “New Horizons”) an association 
between increasing age and more functional small airway 
abnormality (PRMFSA) was found, with an increase in 
PRMFSA per decade of age, ranging from 3.6% in the 5th 
decade to 12.7% in the 8th decade [36]. Moreover, the 
contribution of aging to greater PRMFSA was different in 
presence of established obstruction, with a 4.2% higher 
PRMFSA per decade among subjects with obstruction, 
versus a 2.7% higher PRMFSA per decade among those 
without airflow obstruction [36]. 
- Secretions. They are a common finding in elderly 
airways, usually presenting low attenuation and “bubbly” 
appearance, due to commixture with air. They more 
commonly occur along the dependent portion of the 
airway. 
- Senile lung. Aging modifications of the lower 
airways superimposed on an increase of pulmonary 
supporting interstitial connective tissue and on a 
homogeneous reduction of pulmonary vascularization 
create the so-called “dirty chest” on CXR [27]. This is 
characterized by a reduction in lung opacity and 
vascularity, linear and reticular opacities, cystic air 
spaces, bronchial thickening, and bronchial dilation [37]. 
These findings are very common in the elderly and do not 
represent frank disease. 
Clinically relevant airway diseases occurring more 
commonly in older people than in younger adults are 
COPD, CPFE, bronchiectases (Fig. 3), bronchiolitis 
(Fig. 3B), expiratory central airway collapse, bronchial 
anthracofibrosis, broncholithiasis, and neoplasms. The 
main features and the clinical relevance of these diseases 
in older people are summarized in Table 2. There are also 
airway diseases occurring less commonly than in adults, 
such as infiltrative diseases like sarcoidosis.  
On one hand, physicians prescribe an imaging study 
of the airways when a clinical suspicion of disease exists 
to characterize the disease itself. On the other hand, the 
identification of imaging findings of airway disease 
cannot directly translate into prescription of respiratory 
drugs. For example, in case of CT-defined COPD there is 
no evidence that the cost/benefit ratio of daily COPD 
inhalers is favorable for these patients unless their FEV1 





Figure 3.  Clinically relevant airway disease. Comparison between bronchiectases (A) and bronchiolitis due to 
underlying bronchiectases (b). CT is diagnostic in both cases showing in the first case (A) dilated bronchi with cystic 
appearance (arrow) whereas in the second case (B) dilated bronchi with cylindrical and varicose (black arrow) appearance, 
together with bronchial mucoid impaction (black asterisk), thickening of bronchial walls (thin white arrows), centrilobular 
nodules and consolidations (circle). The patchy and asymmetric distribution of the above-mentioned findings is typical of 
infectious bronchiolitis. Note the “signet ring sign” (thick white arrow) typical of bronchiectasis, due to the greater diameter 
of the bronchus in comparison to the adjacent artery. 
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Figure 4. Post-processing imaging techniques: 2D and 3D reconstruction images. Axial CT scan (A) shows an 
endobronchial mass (black arrow) within right main bronchus in a 78 years-old man with squamous cell carcinoma, causing 
partial collapse of right lung with displacement of mediastinum towards right (white arrows). 3D virtual bronchoscopy (B, C) 
reproduces the bronchoscopic appearance of the mass occluding right main bronchus (arrow in b), but it allows more than 
bronchoscopy the visualization of the patent bronchi distal to obstruction site (C). Curved 2D MPR (multiplanar 
reconstructions) image (D) better depicts the cranio-caudal extent of the mass (arrow) into right main bronchus than the axial 
image (A). CT bronchography (E) allows a global visualization of the aerated lung and shows the site of interruption (arrow) 
of the tracheobronchial tree. 
 
An integrated diagnostic approach: our daily horizon 
in clinical practice 
 
Older patients with dyspnea, cough, wheezing, or 
recurrent respiratory infections should undergo an 
accurate clinical evaluation, including PFTs. In many 
cases this approach allows the diagnosis of well-defined 
respiratory conditions with an obstructive pattern, more 
commonly in patients with COPD and asthma, and a 
restrictive pattern, more commonly in patients with 
interstitial lung disease and rib cage deformity. However, 
conditions with univocally categorized obstructive or 
restrictive pattern on PFTs may indeed be atypical in older 
patients. On the one hand, bronchial obstruction may be 
only to some extent reversible and clinical presentation in 
older asthmatics may be misleading (see above) [10]. On 
the other hand, older people can present mixed patterns on 
PFTs, i.e. to a variable extent obstructive and restrictive, 
more commonly than younger adults. For instance, an 
older patient with COPD, congestive heart failure, and 
sarcopenia is expected to have a mixed pattern, but it is 
difficult to dissect out the individual contribution of each 
separate condition on a purely clinical basis. Imaging may 
help in identifying and staging comorbid conditions 
contributing to such a mixed pattern. However, more 
commonly it is the combination of clinical data and 
imaging findings that permits a correct diagnosis and 
management. Overall, patients with a restrictive pattern at 
PFTs need to undergo a chest CT scan to diagnose any 
interstitial lung disease or extra-pulmonary disorders, 
such as chest wall abnormalities, rib and vertebral 
fractures, pleural effusion and pleural disease, 
diaphragmatic dyskinesia, and sarcopenia (obesity and 
chronic heart failure can also cause a restrictive pattern, 
but clinical presentation is diagnostic). Conversely, 
patients presenting with an obstructive pattern at PFTs 
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need a CXR for a first diagnostic evaluation, followed by 
a chest CT scan in all those patients requiring a deep 
insight. Indeed, patients with large airway disease require 
a chest CT scan to assess the presence of stenoses, 
broncholithiasis, relapsing polychondritis, trachea-
bronchomalacia, and excessive dynamic airway collapse 
(EDAC). In particular, patients with suspected large 
airway disease and without imaging findings of large 
airway disease at CT performed at end-inspiration need a 
specific expiratory scan to diagnose 
tracheobronchomalacia, EDAC, or relapsing 
polychondritis. Patients with an obstructive pattern at 
PFTs with lower airway disease need to be studied by CT 
scan, as it can reveal bronchiolitis, bronchiectasis, 
bronchial thickening in cardiac failure, as well as COPD 
with its specific phenotype. Patients with asthma 
represent an exception, as they can be studied clinically 
and on CXR. Variations should be considered according 
to individual conditions and prognosis as well as timing 
and circumstances of CT examination should be carefully 
scrutinized. Findings of airway disease incidentally found 
on CXR or CT performed for other reasons require 
afterwards an accurate clinical evaluation. This can occur 
in case of bronchiectases, diverticula, broncholithiasis, 
and bronchiolitis. For instance, bronchiectases may be 
completely silent, mainly if located in the apical regions, 
or may cause recurrent or chronic respiratory symptoms 
generically ascribed to bronchitis before performing CT 
scan. 
Diffusing lung capacity of carbon monoxide (DLco) 
can help in daily practice as reflects gas exchanges 
through the alveolar-capillary membrane and can be used 
in assessing both restrictive and obstructive airway 
disease. DLco is an important determinant of the clinical 
phenotype of COPD, being more reduced in emphysema-




Table 1. Imaging specifics for chest CT evaluation of airway disease in older people. 
 
MDCT CT scans to better assess the airways (from the trachea to the most distal visible bronchi) 
are multidetector CT scans (MDCT), widely spread in Western countries. MDCT scans 
allow generating 2D multiplanar and 3D reconstructions of the airways. 
Patient positioning Can be challenging in those with musculoskeletal problems. Rotation of the gantry can be 
helpful in obtaining axial scans even in severe dorsal kyphosis. 
Patient Dose Moderate radiation doses are acceptable at inspiratory CT scan (<10 mSv). Expiratory CT 
may be performed with lower radiation exposure (tube current ≤ 50 mAs) [43]. 
Motion artifacts MDCT takes only a few seconds to scan the entire chest, reducing or avoiding motion 
artifacts even in breathless patients. 
Intravenous contrast media Routinely not recommended. Required in known or suspected airway neoplasms, 
paratracheal masses causing airway obstruction, and in suspected pulmonary embolism. In 
case of contrast administration, glomerular filtration rate should always be performed, as 
normal values of creatinine in the blood for the adult population are not consistent with a 
good renal function in older population. 
Breathing instructions Fundamental to avoid motion artifacts and misleading diagnoses of airway disease. Issues in 
accurately following breathing instructions are more common than in younger adults, 
because of ear loss, dyspnea, cough, weakness of chest wall muscles, or cognitive 
impairment. A better compliance in following breathing instructions can be obtained by 
showing the procedure to the patient as well as by careful coaching the patient before and 
during the examination. Coaching consists of making the old patient comfortable with the 
instructions, ensuring him that the instructions will be repeated during the examination and 
he does not have to remember everything, and giving him the chance to try the protocol 
more times as needed [55]. 
(MDCT= Multidetector Computed Tomography; 2D= two dimensional; 3D= three dimensional; mSv= millisievert; mAs= milliamper/second) 
 
Bronchoscopy can provide additional information to 
clinical and imaging data in the study of the airways also 
in elderly subjects, as it can be performed safely and 
effectively in this subset of population, with only one 
report of a greater incidence of adverse reactions in 
patients 80 years or older [40]. Bronchoscopy allows also 
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the study of wall changes and endobronchial mucosal 
vasculature in COPD patients [41]. Bronchoscopy-related 
procedures, such as endobronchial ultrasounds and 
transbronchial needle aspiration, are also safe and 
effective, even though they are invasive and might not be 
well tolerated by the elderly [42]. Endobronchial 
interventions including radiotherapy, laser therapy, 
photodynamic therapy, cryotherapy, and airway stenting 
can be performed in cases of large airway stenoses as well 
as neoplasms, with either palliative or therapeutic aim 
[43]. They can also represent a “bridge” treatment of 
severe dyspnea and hemoptysis before surgery. Finally, in 
COPD patients lung volume reduction performed via 
bronchoscopy can produce a significant improvement in 
lung function in patients with heterogeneous emphysema 
and intact interlobar fissures by using endobronchial 
valves [44]. Coils, vapor thermal ablation, and sclerosant 
agents are alternative to endobronchial valves, but they 
should be used in more specific settings [45]. Chest CT 
scan with 2D and 3D reconstructions is fundamental in all 
types of bronchoscopy-related procedures, in both pre-






Figure 5.  Post-processing imaging techniques: quantification of emphysema and air-trapping.  Quantification in a 
73 years-old woman with COPD by using dedicated software of semi-automatic lung volume segmentation (Franhofer 
MeVis, Germany, DE). Volume rendering CT images at end-inspiration (A) and end-expiration (B) show pulmonary 
lobes with different colours and low attenuation areas as orange dots. At end-inspiration (A) the dots represent areas with 
attenuation values below -950 HU consistent with emphysema, whereas at end-expiration (B) the dots represent areas 
with attenuation values below -856 HU, consistent with air-trapping and emphysema. 
 
New horizons: analysis of exhaled gases, post-
processing imaging techniques, and genetic analysis 
 
The dramatically rising prevalence of respiratory diseases 
in older people requires that, as previously done for 
cognitive problems or heart failure, geriatricians become 
highly skilled in both traditional and innovative rapidly 
evolving diagnostic strategies for evaluating the airways. 
The analysis of exhaled gases qualifies as a promising 
way of studying lung function. It can focus on selected 
exhaled gases, which can be determined through different 
analytical methods, such as high-performance liquid 
chromatography (HPLC) or mass spectrophotometry. 
Alternatively, a comprehensive non-qualitative picture of 
exhaled gases can be obtained by using the electronic 
nose, the so-called “e-nose” [46]. The ensuing breath 
pattern may be viewed as a sort of metabolic marker, 
reflecting non-respiratory diseases that impact the overall 
metabolism, e.g. liver failure and congestive heart failure. 
The available evidence on the e-nose shows an optimal 
diagnostic capacity for lung neoplasms, even at their 
initial stages [47]. Furthermore, the e-nose can help in 
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classifying patients with COPD and can detect changes in 
breath pattern after nocturnal ventilation in patients with 
Obstructive Sleep Apnea [48]. The breath pattern 
measures have good reproducibility in both healthy and 
COPD subjects [49]. This dedicated tool collects the 
exhaled air and stores it, requiring the proband only to 
breath quietly through the mouthpiece, without the need 
of a nasal ring (European patent n. 2641537 (A1) ― 2013-
09-25). This makes the procedure easy and comfortable, 
thus suitable even for the most frail and disabled older 
subjects. Noteworthy, the cost of air collection and 
examination may range is about 20 to 25$. This bulk of 
evidence makes the e-nose technology very promising for 
the study of older patients. Diagnostic applications of e-
nose can be helpful in non-collaborating and disabled 
patients as well as in uncertain diagnoses of airway 
disease and in phenotypic characterization of certain 
chronic airway disease. Thus, it is likely that in the next 
future the e-nose may become a primary diagnostic tool 
in the older population.  
As regards imaging, data obtained by a CT scan can 
be post-processed to generate high quality two-
dimensional multiplanar reconstructions and 3D 
reconstructions that deliver a more anatomically 
meaningful display of the airways and improve 
communication among radiologists, clinicians, and 
patients [50, 51] (Fig. 4). 3D reconstructions include CT 
bronchography, an accurate roadmap of large airways, 
and virtual bronchoscopy, a simulation of the endoscopic 
navigation through the tracheobronchial tree (Fig. 4). In 
particular, virtual bronchoscopy represents a non-invasive 
alternative to conventional bronchoscopy in older adults 
and very sick patients and a non-invasive technique for 
long-term monitoring of tracheobronchial stents, with 
potential to replace conventional bronchoscopy in stent 
surveillance These techniques are not routinely performed 
in daily clinical practice yet, but nowadays they are 
commonly used for research purposes. 
Patients with COPD can take advantage of new 
diagnostic tools of automated detection and quantification 
of the extent of emphysema and expiratory air-trapping 
(Fig. 5), as well as changes in airway walls. The 
automated quantification of emphysema extent within 
each single lobe allows an accurate selection of preferred 
candidates for surgery or endoscopy. Those patients 
undergoing a surgical intervention for lobectomy, due to 
either asymmetric emphysema or lung tumors, may 
benefit from a pre-surgical evaluation of the remaining 
healthy as well as pathological lung volume by using a 
specific post-processing technique, called “virtual 
lobectomy” (Fig. 6). Furthermore, patients with COPD 
can nowadays receive a straightforward phenotypization 
of disease by using a co-registration technique, based on 
automated co-registration of inspiratory and expiratory 
CT scans [36, 52]. This technique provides radiologists 
and clinicians with a quantitative overview of the lungs in 
parametric response maps (PRM), with the relative 
volume of normal parenchyma, persistent airway disease, 
and functional small airway disease (PRMFSA) (see air-
trapping in the section “Imaging findings between normal 
aging and clinically relevant airway disease”) (Fig. 7).  
An integrated approach to both visual and 
quantitative assessment of CT scans is fundamental in 
evaluating patients with COPD, as described in the 
statement by the Fleischner Society on CT-definable 
subtypes of COPD [53]. The statement encourages such 
an approach to improve personalized care of patients, 
taking into account not only lung emphysema, but also 
coexisting findings: large airway disease, bronchiectases, 






Figure 6. Post-processing imaging techniques: virtual lobectomy. Axial CT image at lung window setting (A) 
shows a mass (arrow) in the apical segment of right upper lobe in a 73 years-old man, proved to be an invasive 
adenocarcinoma. Lung volume segmentation performed by using semi-automated software (Thoracic VCAR, GE 
Healthcare, Milwaukee, WI) allows to separate each lobe along the fissures (B, C) and to obtain the volume of 
emphysema (blue dots) within each lobe. 
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Another innovative imaging analysis is the fractal 
dimension analysis. It has been performed on CT images 
to study the aged lung [54], revealing a significant 
decrease in lung complexity and lung density with age in 
never smokers. However, the exact histopathological 
basis for this finding in older individuals is unknown. 
Further studies on fractal dimensions are needed to 
investigate more specifically the aging airways. 
Ultrasounds analysis of diaphragm kinetics has been 
evaluated as an additional imaging tool in assessing 
airway obstruction [55]. Indeed, the M-mode index of 
obstruction (ratio between forced expiratory 
diaphragmatic excursion in the first second and maximum 
expiratory diaphragmatic excursion) has been shown to 
represent a speed index of diaphragmatic relaxation, 
significantly correlated with FEV1/VC (p < 0.0001) [56]. 
An index value < 77 was identified as a possible cut-off 
for suspecting an obstructive airway disease (positive 
predictive value: 95.5%), thus representing a potentially 
helpful tool in screening obstructive airway disease in 





Figure 7. Post-processing imaging techniques: PRM in co-registration analysis. Co-registration of inspiratory and expiratory CT 
scans (Imbio LLC, Minnesota, MN) provides a quantitative overview of the lungs (parametric response maps - PRM), with the relative 
volume of normal parenchyma (green), persistent airway disease (red), and functional airway disease (yellow). This innovative 
approach allows phenotypization of COPD without the need of an operator, as it is completely automated. Case “A” is a patient with 
predominant conductive airway disease (47% functional low-density area and 14% persistent low density area), whereas case “B” is a 
case with predominant emphysema (25% functional low density area and 55% persistent low density area). 
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Table 2. Clinically relevant airway disease in older people: clinical relevance and role of imaging. 
 
Airway disease Clinical relevance in older people Imaging 
COPD High prevalence in older people.  
Overdiagnosed if the normal threshold for adults is 
considered (FEV1/FVC <70%). 
Increasing role of imaging in phenotyping the disease. 
Challenge in distinguishing COPD from asthma cases 
and from cases with ACOS (Asthma-COPD Overlap 
Syndrome), common in older people [11].  
Imaging may provide a structured morphometric analysis 
of both large and small airways, with the evaluation of 
parenchymal destruction, bronchial wall thickening as well 
as air-trapping. This approach allows distinguishing 
different phenotypes, such as predominant emphysema 
and predominant conductive airway disease. This 
distinction is the key for targeting patient therapy and 
selecting candidates for surgical or endoscopical therapy. 
CPFE Most often observed in 65 years-old men, cigarette 
smokers or ex-smokers of >40 pack-years [67]. PFTs 
show spurious preservation of lung volume together 
with depression of gas transfer. 
CT shows centrilobular and/or paraseptal emphysema in 
upper zones and diffuse interstitial lung disease at the 
bases (subpleural reticular opacities, honeycomb, traction 
bronchiectasis, and more frequent ground-glass opacities 
than in idiopathic pulmonary fibrosis). 
Bronchiolitis Aspiration and infectious bronchiolitis are the most 
common forms in older people. Aspiration 
bronchiolitis is caused by recurrent aspiration of 
gastric contents or foreign bodies, common in older 
people. Infectious bronchiolitis is caused by 
immunodeficiency and ineffectiveness of mucociliary 
clearance, part of the physiological aging. 
CXR shows diffuse, unilateral or bilateral, small (<5 mm) 
nodular lung opacities.  
CT shows centrilobular nodules and tree-in-bud opacities 
associated with adjacent areas of lobular consolidation. A 
patchy and asymmetric distribution is seen in infectious 
bronchiolitis, whereas dependent areas are more 
commonly affected in aspiration bronchiolitis. 
Bronchiectases Their diagnosis often clarifies otherwise unexplained 
respiratory symptoms. Older people are more prone to 
develop bronchiectases due to their immunodeficiency 
and weaken mucociliary clearance. Bronchiectases can 
cause recurrent tracheobronchial infections, 
hemoptysis, cough, systemic inflammation, respiratory 
failure. Traction bronchiectases are a relevant finding 
in interstitial lung disease. 
CXR is often negative. 
CT is diagnostic, showing dilated and thickened bronchi 
without distal tapering. Cylindrical, varicose, or cystic 
appearance. Air-trapping, bronchial mucoid impaction, 
and pulmonary atelectasis can coexist. Traction 
bronchiectases are localized in areas of interstitial lung 
involvement, either within the reticular pattern or in the 
ground-glass pattern. 
ECAC Commonly underdiagnosed for its diagnostic 
challenge. ECAC includes tracheobronchomalacia and 
excessive dynamic airway collapse and it causes a 
worse respiratory quality of life. ECAC is more 
common in older subjects (mean age: 65±8.6) and in 
COPD patients [68]. 
In collaborating COPD patients with high clinical 
suspicion for excessive expiratory tracheal collapse a 
dynamic forced expiratory scan should be preferred to 
static end-expiratory scan [68]. On CT a reduction in 
cross-sectional tracheal area >50% is diagnostic in adults, 
with 70-80% cut-off being more specific [69]. However, 
no specific threshold of reduction in airway lumen has 
been suggested yet for older people. 
Bronchial 
anthracofibrosis 
Typical presentation in older women suffering from 
chronic cough, sputum, and dyspnea, and without a 
relevant history of pneumoconiosis or smoking [70]. 
CT scan shows multifocal stenoses of lobar and segmental 
bronchi in right upper lobe and right middle lobe, with 
peribronchial soft tissue thickening, calcified or non-
calcified lymph nodes, and lobar or segmental atelectasis 
distal to the involved bronchi. 
Broncholithiasis Higher prevalence than younger adults because of high 
incidence of foreign body aspiration and calcified 
lymph nodes.  
Higher complication rate than younger adults. 
Complications like massive hemoptysis and 
obstructive pneumonia are very common in older 
people, causing significant morbidity and a difficult 
management. 
CT scan shows calcified body (broncholith) within the 
lumen of the tracheobronchial tree along with post-
obstructive findings, including bronchiectasis, 
consolidation and air-trapping. 
Neoplasms As age increases airway neoplasms more likely occur. 
However, benign airway neoplasms present with a 
higher incidence in older people. In two recent large 
series of primary benign airway tumors [71, 72] a 
higher occurrence in subjects older than 60 years was 
reported, but without a significant prevalence of any 
specific histotype. Endoscopical treatment can be 
curative in benign neoplasms. 
CT scan shows intraluminal masses or airway wall 
thickening, with or without involvement of adjacent 
structures. CT is fundamental for staging and follow-up.  
Benign airway neoplasms are usually discovered 
incidentally on CT scans performed for other reasons. 
 
(COPD= chronic obstructive pulmonary disease; CPFE= combined pulmonary fibrosis and emphysema; CT= Computed Tomography; ECAC= 
expiratory central airway collapse) 
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Magnetic resonance imaging (MRI) of the lung has 
been recently used in assessing COPD patients in 
comparison with PRM [57]. Ventilation defects at 3He 
MRI were quantitatively and spatially related to PRM gas-
trapping in subjects with mild to moderate COPD, 
whereas they were related to both PRM gas-trapping and 
emphysema in subjects with severe COPD [57]. However, 
future studies should ascertain the spatial relationships 
between continuous pixel-wise data and PRM to provide 
a deeper insight of these relationships. Beyond COPD, 
lung MRI has also been used to evaluate the response to 
therapy in asthmatic patients using a turbo-inversion 
recovery-magnitude sequence. This sequence shows the 
extent of the segmental lung edema that corresponds to 
the severity of the regional allergic reaction, representing 
a promising biomarker for the non-invasive detection of 
the inflammatory response in asthmatic patients [58]. 
Another technique in combination between imaging 
and bronchoscopy is the endobronchial optical coherence 
tomography (EB-OCT), which can detect abnormalities 
of airway architecture in both large and medium-to-small-
sized airways. Findings of airway remodeling have been 
found more pronounced in COPD patients, followed by 
smokers with normal FEV1 and never-smokers [59].  
Genomic studies have recently been added in the 
spectrum of possible tools to better characterize COPD 
patients. In addition to the well-know deficiency of α1-
antitrypsin as genetic cause of panlobular emphysema, 
several genome-wide associations studies (GWAS) have 
found specific loci on genes associated with COPD, 
including FAM13A, PID1, CHRNA3/5, IREB2, HHIP, 
AGER, SERPINA10, MOCS3, IFIT3, and DLC1 [60-64]. 
Noteworthy Cho MH et al [62] showed the associations 
between genes and imaging subtypes in 12,031 patients, 
opening a new horizon on the differential genetics of 
COPD phenotypes. However, GWAS are incapable of 
distinguishing causal from noncausal variants of COPD, 
thus suggesting the relevance of epigenetic investigations. 
By studying previously identified GWAS, DNA 
methylation profiling has identified FRMD4A, THSD4, 
and C10orf11 as the top differentially methylated sites 
[65]. Although several approaches (in vivo, in vitro, in 
silico) can be used for functional translation of genetic 
findings, this translation is still under investigation [66]. 
In next future identified genes and epigenetic variations 
might become effective drug targets or specific 




Nowadays a multidimensional assessment and 
interpretation of the aging airways can be used in our daily 
clinical practice by integrating clinical data together with 
morphologic and morphometric findings to disclose 
isomorphies (i.e. comparable trends of different 
dimensions) as to define the normal aging of the 
respiratory system and the disease status. Thus, a strict 
cooperative work between geriatricians, radiologists, and 
respiratory physiologists is highly desirable and many 
efforts should be done in this direction.  
The multidimensional assessment in the context of a 
multidisciplinary approach lays the basis for a 
comprehensive geriatric assessment, a “technology of the 
geriatric care”, that optimizes the delivered care and 
inherent outcomes. 
In next future, the implementation of the analysis of 
exhaled gases, post-processing imaging techniques, and 
genetic analysis of the older patient will hopefully close 
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